Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 203

The DOI matches its Crossref record.

Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression

Open access
Putluri, Nagireddy, Shojaie, Ali, Vasu, Vihas T., Vareed, Shaiju K., Nalluri, Srilatha, Putluri, Vasanta, Thangjam, Gagan Singh, Panzitt, Katrin, Tallman, Christopher T., Butler, Charles, Sana, Theodore R., Fischer, Steven M., Sica, Gabriel, Brat, Daniel J., Shi, Huidong, Palapattu, Ganesh S., Lotan, Yair, Weizer, Alon Z., Terris, Martha K., Shariat, Shahrokh F., Michailidis, George, Sreekumar, Arun·2011·Cancer Research

Abstract

Although alterations in xenobiotic metabolism are considered causal in the development of bladder cancer, the precise mechanisms involved are poorly understood. In this study, we used high-throughput mass spectrometry to measure over 2,000 compounds in 58 clinical specimens, identifying 35 metabolites which exhibited significant changes in bladder cancer. This metabolic signature distinguished both normal and benign bladder from bladder cancer. Exploratory analyses of this metabolomic signature in urine showed promise in distinguishing bladder cancer from controls and also nonmuscle from muscle-invasive bladder cancer. Subsequent enrichment-based bioprocess mapping revealed alterations in phase I/II metabolism and suggested a possible role for DNA methylation in perturbing xenobiotic metabolism in bladder cancer. In particular, we validated tumor-associated hypermethylation in the cytochrome P450 1A1 (CYP1A1) and cytochrome P450 1B1 (CYP1B1) promoters of bladder cancer tissues by bisulfite sequence analysis and methylation-specific PCR and also by in vitro treatment of T-24 bladder cancer cell line with the DNA demethylating agent 5-aza-2′-deoxycytidine. Furthermore, we showed that expression of CYP1A1 and CYP1B1 was reduced significantly in an independent cohort of bladder cancer specimens compared with matched benign adjacent tissues. In summary, our findings identified candidate diagnostic and prognostic markers and highlighted mechanisms associated with the silencing of xenobiotic metabolism. The metabolomic signature we describe offers potential as a urinary biomarker for early detection and staging of bladder cancer, highlighting the utility of evaluating metabolomic profiles of cancer to gain insights into bioprocesses perturbed during tumor development and progression. Cancer Res; 71(24); 7376–86. ©2011 AACR.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-11-1154

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 203

Metadata

Authors
Putluri, N., Shojaie, A., Vasu, V. T., Vareed, S. K., Nalluri, S., Putluri, V., Thangjam, G. S., Panzitt, K., Tallman, C. T., Butler, C., Sana, T. R., Fischer, S. M., Sica, G., Brat, D. J., Shi, H., Palapattu, G. S., Lotan, Y., Weizer, A. Z., Terris, M. K., Shariat, S. F., Michailidis, G., & Sreekumar, A.
Venue
Cancer Research
Published
2011-12-15
Volume
71
Issue
24
Pages
7376-7386
ISSN
  • 0008-5472 (ISSN-L)
  • 1538-7445
OpenAlex
W2086905232
Cited by
203
References
0
FWCI
4.82
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression. https://app.cochat.ai/papers/10.1158/0008-5472.can-11-1154
The paper
Putluri, N., Shojaie, A., Vasu, V. T., Vareed, S. K., Nalluri, S., Putluri, V., Thangjam, G. S., Panzitt, K., Tallman, C. T., Butler, C., Sana, T. R., Fischer, S. M., Sica, G., Brat, D. J., Shi, H., Palapattu, G. S., Lotan, Y., Weizer, A. Z., Terris, M. K., . . . Sreekumar, A. (2011). Metabolomic Profiling Reveals Potential Markers and Bioprocesses Altered in Bladder Cancer Progression. Cancer Research. https://doi.org/10.1158/0008-5472.can-11-1154

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.